STRATA Skin Sciences (SSKN) EPS (Weighted Average and Diluted) (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136.11% |
| Sep 30, 2025 | 41.94% |
| Jun 30, 2025 | -21.57% |
| Mar 31, 2025 | 55.65% |
| Dec 31, 2024 | -125.49% |
| Sep 30, 2024 | -1,600.00% |
| Jun 30, 2024 | 70.00% |
| Mar 31, 2024 | 90.74% |
| Dec 31, 2023 | -260.00% |
| Sep 30, 2023 | 66.67% |
| Jun 30, 2023 | -1,025.00% |
| Mar 31, 2023 | -2,214.15% |
| Dec 31, 2022 | 88.48% |
| Sep 30, 2022 | 40.00% |
| Jun 30, 2022 | 28.57% |
| Mar 31, 2022 | -133.33% |
| Dec 31, 2021 | -50.00% |
| Sep 30, 2021 | -166.67% |
| Jun 30, 2021 | 142.86% |
| Mar 31, 2021 | -600.00% |
| Dec 31, 2020 | 75.00% |
| Sep 30, 2020 | 20.00% |
| Jun 30, 2020 | -66.67% |
| Mar 31, 2020 | -200.00% |
| Dec 31, 2019 | 66.67% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 25.00% |
| Mar 31, 2019 | -300.00% |
| Dec 31, 2018 | 200.00% |
| Sep 30, 2018 | 71.43% |
| Jun 30, 2018 | 41.67% |
| Mar 31, 2018 | -103.08% |
| Dec 31, 2017 | 183.84% |
| Sep 30, 2017 | -46,500.00% |
| Jun 30, 2017 | 100.55% |
| Mar 31, 2017 | -731.82% |
| Dec 31, 2016 | 72.15% |
| Sep 30, 2016 | 32.48% |
| Jun 30, 2016 | 10.00% |
| Mar 31, 2016 | -966.67% |
| Dec 31, 2015 | 111.19% |
| Sep 30, 2015 | -32.67% |
| Jun 30, 2015 | 9.82% |
| Sep 30, 2014 | -466.67% |
| Sep 30, 2013 | 0.00% |